Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry

被引:64
作者
Koseki, Nozomu [1 ]
Kawashita, Hiroto [1 ]
Hara, Hisanori [1 ]
Niina, Miyuki [1 ]
Tanaka, Makoto [1 ]
Kawai, Ryosei [1 ]
Nagae, Yusuke [1 ]
Masuda, Naoki [1 ]
机构
[1] Novartis Pharma KK, Tsukuba Res Inst, Drug Metab & Pharmacokinet, Tsukuba, Ibaraki 3002611, Japan
关键词
liquid chromatography-tandem mass spectrometry; valsartan; human pharmacokinetics; matrix effects; inter-subject variability;
D O I
10.1016/j.jpba.2006.12.030
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of valsartan in human plasma was developed and validated. A 0.5 ml aliquot was extracted using solid-phase extraction in an Empore(R) high performance extraction disk plate, universal resin 96-well formal. The estimated calibration range of the method was 2-2000 ng/ml. The method was fully validated with intra-day mean accuracy and precision of 94.8-107% and 2.19-5.40% and inter-day mean accuracy and precision of 93.5-105% and 1.87-5.67%, respectively. No significant loss of valsartan in processed samples was confirmed in processed samples for up to 24h at 10 degrees C. Sample dilution up to 50-fold with blank human plasma provided acceptable analyses. No interference peaks or matrix effects were observed. No effect of QC sample location results was observed in a 96-well plate. This LC-MS/MS technique was found to improve quantitative determination of valsartan allowing its pharmacokinetic evaluation with clinically relevant doses. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1769 / 1774
页数:6
相关论文
共 14 条
[1]  
BRUNNER LA, 1994, LAB ROBOTICS AUTOMAT, V6, P171
[2]   High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method [J].
Daneshtalab, N ;
Lewanczuk, RZ ;
Jamali, F .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 766 (02) :345-349
[3]   Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man [J].
Flesch, G ;
Muller, P ;
Lloyd, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (02) :115-120
[4]  
*GUID IND BIOAN ME, 2001, US DEP HHS FOOD DRUG
[5]   Improvement in precision of the liquid chromatographic-electrospray ionization tandem mass spectrometric analysis of 3′-C-ethynylcytidine in rat plasma [J].
Kitamura, R ;
Matsuoka, K ;
Matsushima, E ;
Kawaguchi, Y .
JOURNAL OF CHROMATOGRAPHY B, 2001, 754 (01) :113-119
[6]   Simultaneous quantitative determination of cyclosporine A and its three main metabolites (AM1, AM4N and AM9) in human blood by liquid chromatography/mass spectrometry using a rapid sample processing method [J].
Koseki, N ;
Nakashima, A ;
Nagae, Y ;
Masuda, N .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2006, 20 (05) :733-740
[7]   Rapid determination of valsartan in human plasma by protein precipitation and high-performance liquid chromatography [J].
Macek, J ;
Klíma, J ;
Ptácek, P .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2006, 832 (01) :169-172
[8]   Valsartan - A review of its pharmacology and therapeutic use in essential hypertension [J].
Markham, A ;
Goa, KL .
DRUGS, 1997, 54 (02) :299-311
[9]   AUTOMATED-DETERMINATION OF AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, CGP-48-933, IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
SIOUFI, A ;
MARFIL, F ;
GODBILLON, J .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1994, 17 (10) :2179-2186
[10]   Liquid-liquid extraction in the 96-well plate format with SRM LC MS quantitative determination of methotrexate and its major metabolite in human plasma [J].
Steinborner, S ;
Henion, J .
ANALYTICAL CHEMISTRY, 1999, 71 (13) :2340-2345